IMRN Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Valuation Metrics

The current forward P/E ratio for Immuron Ltd (IMRN.O) is -64.94, compared to its 5-year average forward P/E of -24.86. For a more detailed relative valuation and DCF analysis to assess Immuron Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-24.86

Current PE

-64.94

Overvalued PE

21.65

Undervalued PE

-71.37

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

3.46

Current PS

1.12

Overvalued PS

6.21

Undervalued PS

0.72

Financials

Annual

Quarterly

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

IMRN News & Events

Events Timeline

No data

News

9.5

10:53 AMBenzinga

B. Riley Financial Shares Surge Approximately 25%; Check Out 20 Stocks Making Moves in Premarket Trading

2.0

12-04Benzinga

UiPath Shares Rise Approximately 9%; Check Out 20 Stocks Making Moves in Premarket Trading

7.5

12-03Globenewswire

Immuron Secures US Military Contract for New Oral Therapeutics Targeting Campylobacter and Shigella

People Also Watch

Frequently Asked Questions

What is Immuron Ltd (IMRN) stock price today?

The current price of IMRN is 0.9702 USD — it has decreased -4.9 % in the last trading day.

What is Immuron Ltd (IMRN)'s business?

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), and IMM-529.

What is the price predicton of IMRN Stock?

Wall Street analysts forecast IMRN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IMRN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Immuron Ltd (IMRN)'s revenue for the last quarter?

Immuron Ltd revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is Immuron Ltd (IMRN)'s earnings per share (EPS) for the last quarter?

Immuron Ltd. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for Immuron Ltd (IMRN)'s fundamentals?

The market is revising No Change the revenue expectations for Immuron Limited (IMRN) for FY2026, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -46.98%.

How many employees does Immuron Ltd (IMRN). have?

Immuron Ltd (IMRN) has 6 emplpoyees as of December 16 2025.

What is Immuron Ltd (IMRN) market cap?

Today IMRN has the market capitalization of 7.84M USD.